Metformin hydrochloride,1115-70-4 |
|||||||
|
|
|
Cat.No.: |
IC-0128555 |
|
|
|
Product Information |
|||||||
Biological Activity |
|||||||
Metformin hydrochloride (1,1-Dimethylbiguanide hydrochloride) inhibits the mitochondrial respiratory chain in the liver, leading to activation of AMPK, enhancing insulin sensitivity for type 2 diabetes research. Metformin hydrochloride triggers autophagy[1]. Metformin hydrochloride (1,1-Dimethylbiguanide hydrochloride) inhibits proliferation of ESCs in a concentration-dependent manner. The IC50 is 2.45 mM for A-ESCs and 7.87 mM for N-ESCs. Metformin shows pronounced effects on activation of AMPK signaling in A-ESCs from secretory phase than in cells from proliferative phase[2]. |
|||||||
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines) |
|||||||
Species |
Mouse |
Rat |
Rabbit |
Guinea pig |
Hamster |
Dog |
|
Weight (kg) |
0.02 |
0.15 |
1.8 |
0.4 |
0.08 |
10 |
|
Body Surface Area (m2) |
0.007 |
0.025 |
0.15 |
0.05 |
0.02 |
0.5 |
|
Km factor |
3 |
6 |
12 |
8 |
5 |
20 |
|
Animal A (mg/kg) = Animal B (mg/kg) multiplied by (Animal B Km / Animal A Km) |
|||||||
Order Information |
|||||||
|
Size |
Price($£© |
Price(€) |
Price(£¤/CNY£© |
Price(£¤/JYP£© |
||
1g |
$80.00 |
€ 96.00 |
£¤800.00 |
£¤15,920.00 |
|||
5g |
$120.00 |
€ 144.00 |
£¤1,200.00 |
£¤23,880.00 |
|||
25g |
$199.00 |
€ 238.80 |
£¤1,990.00 |
£¤39,601.00 |
|||
|
Free Delivery on orders over $350.00. |
||||||
Chemical Information |
|||||||
Molecular Weight |
165.62 |
||||||
Formula |
C4H12ClN5 |
||||||
CAS Number |
1115-70-4 |
||||||
Purity |
>98% |
||||||
Solubility |
H2O : 250 mg/mL (1509.48 mM; Need ultrasonic),DMSO : ¡Ý 1.7 mg/mL (10.26 mM) |
||||||
Storage |
at -20¡ãC for 3years,at 2-8¡ãC for 1 year |
||||||
Reference |
|||||||
[1]. Soraya H, et al. Acute treatment with metformin improves cardiac function following NSC 37745 induced myocardial infarction in rats. Pharmacol Rep. 2012;64(6):1476-84. |
|||||||
[2]. Xue J, et al. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis. Reproduction. 2013 Aug 21;146(4):397-406. [3]. Otto M, et al. Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes. Diabetes Obes Metab. 2003 May;5(3):189-94. |
|||||||
We Devoted Ourselves To The Development Of Biomedical Research Reagent. |
|||||||